We recently published a list of 10 Most Buzzing Stocks To Buy Now. In this article, we are going to take a look at where ...

The Centers for Disease Control and Prevention recommends everyone six years and older receive the updated shots.

Pfizer ($PFE) became a household name during the pandemic, and its stock rose along with its fame. However, three years later, the share price has plummeted and ...

KP.2-adapted COVID-19 vaccine received FDA approval. Manufacturing Optimization Program aims to deliver $1.5b in savings by ...

Pfizer and Valneva may have about two more years to wait before they make the first approval filing to the FDA for a Lyme ...

On August 22, Moderna announced that FDA approved its supplemental Biologics License Application ... we saw more than 600,000 hospitalizations due to COVID in the U.S.” On the same day, Pfizer and ...

The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against ...

One of the biopharma industry’s marvels of the 2020s has been the enormous medical and financial success of the GLP-1 class ...

Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on Wednesday night. | Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on ...

Unlike Pfizer/BioNTech and Moderna, Novavax does not use mRNA technology for its COVID-19 vaccine, instead opting for a ...

A third COVID-19 vaccine will be available shortly as Novavax joins Pfizer/BioNTech and Moderna in targeting variants that ...

Geometric Mean Titers were comparably high at one month post first and second booster. Pfizer aims to submit marketing applications to the FDA and the European Medicines Agency in 2026, subject to ...